These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17210522)

  • 21. State of the Art Symposium: flow cytometry in the diagnosis of lymphoproliferative disorders by fine-needle aspiration.
    Jorgensen JL
    Cancer; 2005 Dec; 105(6):443-51. PubMed ID: 16155944
    [No Abstract]   [Full Text] [Related]  

  • 22. Expression of cell surface determinant(s) on murine myeloma stem cells and hematopoietic stem cells.
    Daley MJ; Williams T; Warner NL
    Eur J Immunol; 1984 Dec; 14(12):1096-100. PubMed ID: 6335094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytologic findings of primary thyroid MALT lymphoma with extreme plasma cell differentiation: FNA cytology of two cases.
    Kaba S; Hirokawa M; Kuma S; Maekawa M; Yanase Y; Kojima M; Miyauchi A
    Diagn Cytopathol; 2009 Nov; 37(11):815-9. PubMed ID: 19526579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
    Qi CF; Zhou JX; Lee CH; Naghashfar Z; Xiang S; Kovalchuk AL; Fredrickson TN; Hartley JW; Roopenian DC; Davidson WF; Janz S; Morse HC
    Cancer Res; 2007 Mar; 67(6):2439-47. PubMed ID: 17363561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunophenotyping large B-cell lymphomas. Flow cytometric pitfalls and pathologic correlation.
    Bertram HC; Check IJ; Milano MA
    Am J Clin Pathol; 2001 Aug; 116(2):191-203. PubMed ID: 11488065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
    Tabata R; Yasumizu R; Tabata C; Kojima M
    Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phenotypic analysis of myeloma cells].
    Mihara K; Harada H; Kawano MM
    Nihon Rinsho; 1995 Mar; 53(3):574-9. PubMed ID: 7699888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CD19 and lack of miR-223 distinguish extramedullary plasmacytoma from multiple myeloma.
    Yu SC; Chen SU; Lu W; Liu TY; Lin CW
    Histopathology; 2011 May; 58(6):896-905. PubMed ID: 21401705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mantle cell lymphoma with flow cytometric evidence of clonal plasmacytic differentiation: a case report.
    Naushad H; Choi WW; Page CJ; Sanger WG; Weisenburger DD; Aoun P
    Cytometry B Clin Cytom; 2009 May; 76(3):218-24. PubMed ID: 19061249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry.
    Carulli G; Marini A
    Clin Ter; 2012; 163(1):47-57. PubMed ID: 22362234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antigenic transformation in plasma cell dyscrasia.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Tillman BF; Beason K; Lam J; Koehler J
    Exp Mol Pathol; 2006 Oct; 81(2):157-61. PubMed ID: 16908019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
    Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
    Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma.
    Johnsen HE; Bøgsted M; Klausen TW; Gimsing P; Schmitz A; Kjaersgaard E; Damgaard T; Voss P; Knudsen LM; Mylin AK; Nielsen JL; Björkstrand B; Gruber A; Lenhoff S; Remes K; Dahl IM; Fogd K; Dybkaer K; ;
    Cytometry B Clin Cytom; 2010 Sep; 78(5):338-47. PubMed ID: 20533391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
    Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
    Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flow cytometric expression of common antigens CD18/CD45 in blood from dogs with lymphoid malignancies: a semi-quantitative study.
    Comazzi S; Gelain ME; Riondato F; Paltrinieri S
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):243-52. PubMed ID: 16698089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of flow cytometry immunophenotyping and multidrug resistance assay in B-cell acute lymphoid leukemia and multiple myeloma.
    Jakab K; Gopcsa L; Adam E; Domjan G; Sarkadi B; Paloczi K
    Neoplasma; 2005; 52(1):36-42. PubMed ID: 15739024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B-cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B-cell process.
    Rosado FG; Morice WG; He R; Howard MT; Timm M; McPhail ED
    Br J Haematol; 2015 May; 169(3):368-76. PubMed ID: 25644063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of CD56/CD16 in T-cell acute lymphoblastic leukaemia correlates with the expression of cytotoxic molecules and is associated with worse response to treatment.
    Dalmazzo LF; Jácomo RH; Marinato AF; Figueiredo-Pontes LL; Cunha RL; Garcia AB; Rego EM; Falcão RP
    Br J Haematol; 2009 Jan; 144(2):223-9. PubMed ID: 19016721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.